Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid

Leuk Res. 2007 Oct;31(10):1421-31. doi: 10.1016/j.leukres.2007.03.005. Epub 2007 Jul 12.

Abstract

Differentiation of various leukemic cells can be induced by liganded retinoic acid receptors and protein phosphatase inhibitors. In this study, we explored the effects of okadaic acid (OA), the phosphatase inhibitor, and retinoic acid (RA) in v-myb-transformed monoblasts BM2. OA induced differentiation of BM2 monoblasts into macrophage-like cells, as documented by analyses of cell morphology, cell cycle, phagocytic activity, non-specific esterase activity, production of reactive oxygen species and expression of vimentin and Mo-1. In contrast to many other leukemic cell lines, BM2 cells do not respond to retinoic acid. However, once exposed to OA and RA simultaneously, BM2 cells differentiate along monocyte/macrophage pathway more efficiently. We conclude that RA enhances differentiation of v-myb-transformed monoblasts induced by protein phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Differentiation / drug effects*
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Chickens
  • Genes, myb
  • Immunoblotting
  • Leukemia / metabolism*
  • Macrophages / cytology
  • Macrophages / drug effects
  • Monocytes / cytology
  • Monocytes / drug effects*
  • Okadaic Acid / pharmacology*
  • Transcriptional Activation / drug effects
  • Transfection
  • Tretinoin / pharmacology*

Substances

  • Antineoplastic Agents
  • Okadaic Acid
  • Tretinoin